Guides Collective
The Weekly Guide
Resources, research, and reflections — curated each week for the guides in our community.
JUL 10, 2026
From the Platform
What's new and coming to Guides Collective.
Improving video chat functionality - exploring other video call solutions with end-to-end encryption and are compliant with our privacy standards.
Exploring a better scheduling interface that makes scheduling between guide and seeker simpler and more straight forward.
All questions or tech support issues, please email us at support@guidescollective.com
Section 01
Industry Headlines
What's happening in the psychedelic space this week.
PSYPOST · JUNE 8, 2026
Definium's LSD Therapy Delivers "Profound" Results, Stock Soars 97%
Definium Therapeutics' LSD-based depression treatment produced Phase 3 results analysts called "profound," sending shares up 97% over the past month to roughly $45 apiece. The data adds to a wave of late-stage psychedelic trial wins pushing the sector toward its first FDA approvals.
STARS AND STRIPES · JUNE 2, 2026
Psilocybin Therapy Shows Potential as a Treatment for Anorexia Nervosa in Small Trial
A pilot study of 21 women with long-standing anorexia nervosa found that three psilocybin doses combined with psychotherapy were safe and well-tolerated. Eating disorder symptom severity decreased at every follow-up point, with 48% of participants reaching non-disorder symptom levels by three months.
LUCID NEWS · FEBRUARY 4, 2026
Hamadeh Introduces Bill Requiring Pentagon Review of Emerging PTSD Treatments for Veterans
Congressman Abe Hamadeh introduced legislation requiring the Department of Defense to formally assess emerging PTSD treatments, including psychedelic-assisted therapies, and report findings back to Congress. The bill builds on bipartisan momentum to expand healthcare options for veterans and service members with treatment-resistant PTSD, aligning with the White House's April executive order accelerating research into serious mental illness treatments.
Section 02
From the Field
Perspectives and insights from leaders in the psychedelic space.
MARIJUANA MOMENT · JUNE 4, 2026
Psychedelic Research Gains Momentum Amid Federal Shift From Antidepressants
Connecticut Governor Ned Lamont signed legislation expanding the state’s psychedelic-assisted therapy pilot program to any qualified adults 18 and older, removing prior restrictions limiting participation to veterans and first responders. The law also removes language requiring the program to end upon federal FDA approval, keeping Connecticut eligible for federal matching funds.
EARTH.COM · MAY 22, 2026
Georgia's New Psychedelic Clinic Regulations Take Effect
Researchers at UC Davis developed D5, a novel compound created by exposing amino acids to ultraviolet light that fully activates the brain’s serotonin receptors like classical psychedelics — but produces zero hallucinogenic effects, potentially unlocking depression treatment benefits without the psychedelic experience.
Section 03
Personal Journeys
First-person accounts worth reading — perspectives that inform the work we do.
NORMALIZE PSYCHEDELICS · MAY 6, 2026
Marc Dervaes Lost His Arm in Afghanistan. Ibogaine Helped Him Find Himself Again.
Former bare-knuckle boxing world champion Mark “The Shark” Irwin used psilocybin during his fighting career to enhance performance and confidence — and now relies on the same medicine to support his recovery from traumatic brain injuries sustained through years of professional fighting.
NORMALIZE PSYCHEDELICS · JANUARY 23, 2026
A Nurse's Own Psychedelic Healing Journey: Sherri Mack's Story
At 65, Linda shares how an intentional psilocybin experience after 38 years of sobriety helped her release decades of anger and anxiety — gaining newfound clarity, peace, and the freedom to step away from her business without the worry that had defined her life.